Scientific Sessions 2024  /  Novel Mitral and Tricuspid Valve Therapies: Current Status and A Glimpse into the Future  /  Outcomes Data for TEER in Mitral and Tricuspid Disease
Logo

American Heart Association

  2
  0

Final ID:

Outcomes Data for TEER in Mitral and Tricuspid Disease

  • Sorajja, Paul  ( MINNEAPOLIS HEART INSTITUTE , Minneapolis , Minnesota , United States )
  • Fam, Neil  ( TGH , Toronto , Ontario , Canada )
    • Author Disclosures:
    Paul Sorajja: DO have relevant financial relationships ; Consultant:4C Medical:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:Adona:Active (exists now) ; Consultant:Philips:Active (exists now) ; Consultant:Laza:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:Abbott:Active (exists now) | Neil Fam: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Novel Mitral and Tricuspid Valve Therapies: Current Status and A Glimpse into the Future

Sunday, 11/17/2024 , 03:30PM - 04:30PM

Hall

More abstracts on this topic:
Current Indications for TEER and Transcatheter Therapy in Mitral and Tricuspid Disease

Asgar Anita, Rodes-cabau Josep

Future Landscape of Mitral and Tricuspid Therapies (Including TMVR and TTVR and Other Strategies)

Hahn Rebecca

You have to be authorized to contact abstract author. Please, Login
Not Available